![[Article Title]](https://media.americanpharmaceuticalreview.com/m/28/article/623270-134x100.jpg)
In modern drug development, where speed and efficiency are valued, CDMOs play an important role in driving innovation.
In a recent webinar, experts discussed how Serán Bioscience exemplifies this role with a science-first philosophy that empowers risk-informed decisions to tackle formulation and process problem statements efficiently, reducing the time patients wait for new medicines. Download the article to learn more about smart risk mitigation, robust scale-up strategies, and more.